PROMETHEUS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. - RXDX - Marketscreener.com
Slightly above 67% of Prometheus Biosciences' investor base is looking to short. The analysis of current outlook of investing in Prometheus Biosciences suggests that many traders are alarmed regarding Prometheus Biosciences' prospects. Prometheus Biosciences' investing sentiment can be driven by a variety of factors including economic data, Prometheus Biosciences' earnings reports, geopolitical events, and overall market trends.
Prometheus |
PROMETHEUS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. - RXDX Marketscreener.com
Read at news.google.com
![]() |
Prometheus Biosciences Fundamental Analysis
We analyze Prometheus Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Prometheus Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Prometheus Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Prometheus Biosciences is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Prometheus Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Prometheus Biosciences stock to make a market-neutral strategy. Peer analysis of Prometheus Biosciences could also be used in its relative valuation, which is a method of valuing Prometheus Biosciences by comparing valuation metrics with similar companies.
Peers
Prometheus Biosciences Related Equities
PLRX | Pliant Therapeutics | 4.49 | ||||
VKTX | Viking Therapeutics | 3.06 | ||||
ACLX | Arcellx | 1.88 | ||||
ETNB | 89bio | 1.19 | ||||
IMVT | Immunovant | 0.85 | ||||
AKRO | Akero Therapeutics | 0.40 | ||||
KRYS | Krystal Biotech | 0.00 | ||||
AMLX | Amylyx Pharmaceuticals | 0.94 | ||||
BPMC | Blueprint Medicines | 1.07 | ||||
APLS | Apellis Pharmaceuticals | 1.25 | ||||
TERN | Terns Pharmaceuticals | 1.86 | ||||
ROIV | Roivant Sciences | 2.08 | ||||
STOK | Stoke Therapeutics | 3.39 | ||||
DAWN | Day One | 4.36 | ||||
MDGL | Madrigal Pharmaceuticals | 5.66 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Prometheus Stock
If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data |